Role of Tivozanib in Renal Cell Carcinoma (RCC) - Episode 3
Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.
Related Content:
Kidney Cancer Disparities Persist Among American Indian and Alaskan Native Patients
Tribute to My Husband: A Partner Who Shows Up
Understanding That Not All Lung Cancer Cases Are Linked to Smoking
FDA Fast Tracks FOG-001 After Early Tumor Shrinkage in Desmoid Tumors